A recent study of breast cancer suggested that MSI2 can also suppress epithelial-to-mesenchymal transition (EMT) progression in TNBC MDA-MB-231 cells by regulating the translation of epithelial genes [14]. The gene discussed is MSI2; the disease is breast cancer.